| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sprecher Jeffrey C | Chief Executive Officer, Director | 5660 NEW NORTHSIDE DRIVE, ATLANTA | /s/ Octavia N. Spencer, Attorney-in-fact | 19 Feb 2026 | 0001343882 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ICE | Common Stock | Tax liability | $983,577 | -6,459 | -0.55% | $152.28 | 1,172,781 | 17 Feb 2026 | Direct | F1 |
| transaction | ICE | Common Stock | Options Exercise | $3,401,322 | +50,766 | +4.3% | $67.00 | 1,223,547 | 18 Feb 2026 | Direct | F2 |
| transaction | ICE | Common Stock | Options Exercise | $99,998 | +1,313 | +0.11% | $76.16 | 1,224,860 | 18 Feb 2026 | Direct | |
| transaction | ICE | Common Stock | Sale | $20,139,819 | -129,937 | -11% | $155.00 | 1,094,923 | 18 Feb 2026 | Direct | F2, F3, F4, F5 |
| transaction | ICE | Common Stock | Sale | $23,249,520 | -150,000 | -8.3% | $155.00 | 1,651,705 | 18 Feb 2026 | CPEX | F2, F6 |
| holding | ICE | Common Stock | 81,570 | 17 Feb 2026 | By spouse | F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ICE | Employee Stock Option (right to buy) Holding | Options Exercise | $0 | -50,766 | -33% | $0.000000 | 101,533 | 18 Feb 2026 | Common Stock | 50,766 | $67.00 | Direct | F8 |
| transaction | ICE | Employee Stock Option (right to buy) Holding | Options Exercise | $0 | -1,313 | -0.94% | $0.000000 | 137,845 | 18 Feb 2026 | Common Stock | 1,313 | $76.16 | Direct | F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Represents shares of performance based restricted stock units granted to the filing person on February 12, 2024. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2024 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2025, 1/3 on February 15, 2026 and 1/3 on February 15, 2027). Of the 42,792 shares, 14,264 were issued on February 17, 2026, of which 6,459 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 14,264 shares are scheduled to be issued on February 12, 2027 and taxes for this future issuance will be withheld and reported at the time the shares are issued. |
| F2 | This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 30, 2025. |
| F3 | The common stock number referred in Table I is an aggregate number and represents 1,034,643 shares of common stock and 46,016 unvested restricted stock units ("RSUs"), and 14,264 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. |
| F4 | The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. |
| F5 | The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. |
| F6 | As previously reported, the reporting person also indirectly owns 1,651,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. |
| F7 | As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. |
| F8 | These options are fully vested. |